Human Gut Microbiota for Diagnosis and Treatment of Depression
Top Cited Papers
Open Access
- 26 May 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (11) , 5782
Abstract
Nowadays, depressive disorder is spreading rapidly all over the world. Therefore, attention to the studies of the pathogenesis of the disease in order to find novel ways of early diagnosis and treatment is increasing among the scientific and medical communities. Special attention is drawn to a biomarker and therapeutic strategy through the microbiota–gut–brain axis. It is known that the symbiotic interactions between the gut microbes and the host can affect mental health. The review analyzes the mechanisms and ways of action of the gut microbiota on the pathophysiology of depression. The possibility of using knowledge about the taxonomic composition and metabolic profile of the microbiota of patients with depression to select gene compositions (metagenomic signature) as biomarkers of the disease is evaluated. The use of in silico technologies (machine learning) for the diagnosis of depression based on the biomarkers of the gut microbiota is given. Alternative approaches to the treatment of depression are being considered by balancing the microbial composition through dietary modifications and the use of additives, namely probiotics, postbiotics (including vesicles) and prebiotics as psychobiotics, and fecal transplantation. The bacterium Faecalibacterium prausnitzii is under consideration as a promising new-generation probiotic and auxiliary diagnostic biomarker of depression. The analysis conducted in this review may be useful for clinical practice and pharmacology.Keywords
Funding Information
- Russian Science Foundation (20-14-00132)
This publication has 255 references indexed in Scilit:
- In vitro Effects of Cellulose Acetate on Fermentation Profiles, the Microbiome, and Gamma-aminobutyric Acid Production in Human Stool CulturesCurrent Microbiology, 2023
- Multi-cohort analysis of depression-associated gut bacteria sheds insight on bacterial biomarkers across populationsCellular and Molecular Life Sciences, 2022
- A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress–induced depressive-like behavior in mice by regulating gut microbiota and metabolitesApplied Microbiology and Biotechnology, 2021
- Perturbations in Gut Microbiota Composition in Psychiatric DisordersJAMA Psychiatry, 2021
- Gut microbiota variations in patients diagnosed with major depressive disorder—A systematic reviewBrain and Behavior, 2021
- Psychobiotics: The Next-Generation Probiotics for the BrainCurrent Microbiology, 2021
- Stress, sex hormones, inflammation, and major depressive disorder: Extending Social Signal Transduction Theory of Depression to account for sex differences in mood disordersPsychopharmacology, 2019
- Differential effects of psychotropic drugs on microbiome composition and gastrointestinal functionPsychopharmacology, 2018
- Cell‐to‐cell communication: microRNAs as hormonesMolecular Oncology, 2017
- Depression Is the Leading Cause of Disability Around the WorldJAMA, 2017